These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20835733)

  • 41. Cost-effectiveness and long-term outcomes of liver transplantation using hepatitis B core antibody-positive grafts with hepatitis B immunoglobulin prophylaxis in Korea.
    Kim KD; Lee JE; Kim JM; Lee O; Hwang NY; Rhu J; Choi GS; Kim K; Joh JW
    Clin Mol Hepatol; 2021 Oct; 27(4):603-615. PubMed ID: 34492755
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatitis B virus (HBV) reverse seroconversion (RS) can be prevented even in non-responders to hepatitis B vaccine after allogeneic stem cell transplantation: long-term analysis of intervention in RS with vaccine for patients with previous HBV infection.
    Takahata M; Hashino S; Onozawa M; Shigematsu A; Sugita J; Fujimoto K; Endo T; Kondo T; Tanaka J; Imamura M; Teshima T
    Transpl Infect Dis; 2014 Oct; 16(5):797-801. PubMed ID: 25154638
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of different immunoprophylaxis regimens after liver transplantation with hepatitis B core antibody-positive donors: a systematic review.
    Saab S; Waterman B; Chi AC; Tong MJ
    Liver Transpl; 2010 Mar; 16(3):300-7. PubMed ID: 20209589
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of hepatitis B core antibody-positive donors for liver transplantation.
    Muñoz SJ
    Liver Transpl; 2002 Oct; 8(10 Suppl 1):S82-7. PubMed ID: 12362304
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-HBs levels in infants of hepatitis B carrier mothers after delayed active immunization with recombinant vaccine concomitant with DTP-polio vaccine: is there need for a second dose of HBIg? Dutch Study Group on Prevention of Neonatal Hepatitis B.
    Grosheide PM; del Canho R; Voogd M; Heijtink RA; Schalm SW
    Vaccine; 1994 Sep; 12(12):1059-63. PubMed ID: 7998413
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine.
    Nery JR; Nery-Avila C; Reddy KR; Cirocco R; Weppler D; Levi DM; Nishida S; Madariaga J; Kato T; Ruiz P; Schiff E; Tzakis AG
    Transplantation; 2003 Apr; 75(8):1179-86. PubMed ID: 12717200
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safe use of livers from donors with positive hepatitis B core antibody.
    Manzarbeitia C; Reich DJ; Ortiz JA; Rothstein KD; Araya VR; Munoz SJ
    Liver Transpl; 2002 Jun; 8(6):556-61. PubMed ID: 12037788
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA.
    Ip HM; Lelie PN; Wong VC; Kuhns MC; Reesink HW
    Lancet; 1989 Feb; 1(8635):406-10. PubMed ID: 2563788
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevention of de novo HBV infection by the presence of anti-HBs in transplanted patients receiving core antibody-positive livers.
    Barcena R; Moraleda G; Moreno J; Martín MD; de Vicente E; Nuño J; Mateos ML; del Campo S
    World J Gastroenterol; 2006 Apr; 12(13):2070-4. PubMed ID: 16610059
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictive Factors for Successful Vaccination Against Hepatitis B Surface Antigen in Patients Who Have Undergone Orthotopic Liver Transplantation.
    Ikeda A; Takaki A; Yasunaka T; Oyama A; Adachi T; Wada N; Onishi H; Ikeda F; Shiraha H; Yoshida K; Kuise T; Nobuoka D; Yoshida R; Umeda Y; Yagi T; Fujiwara T; Okada H
    Acta Med Okayama; 2019 Feb; 73(1):41-50. PubMed ID: 30820053
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Active immunization to prevent de novo hepatitis B virus infection in pediatric live donor liver recipients.
    Lin CC; Chen CL; Concejero A; Wang CC; Wang SH; Liu YW; Yang CH; Yong CC; Lin TS; Jawan B; Cheng YF; Eng HL
    Am J Transplant; 2007 Jan; 7(1):195-200. PubMed ID: 17227568
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of hepatitis B core antibody-positive liver allograft in hepatitis C virus-positive and -negative recipients with use of short course of hepatitis B immunoglobulin and Lamivudine.
    Jain A; Orloff M; Abt P; Kashyap R; Mohanka R; Lansing K; Kelley M; Bozorgzadeh A
    Transplant Proc; 2005 Sep; 37(7):3187-9. PubMed ID: 16213345
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Limited hepatitis B immunoglobulin with potent nucleos(t)ide analogue is a cost-effective prophylaxis against hepatitis B virus after liver transplantation.
    Singer GA; Zielsdorf S; Fleetwood VA; Alvey N; Cohen E; Eswaran S; Shah N; Chan EY; Hertl M; Fayek SA
    Transplant Proc; 2015 Mar; 47(2):478-84. PubMed ID: 25769595
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors Affecting the Development of an Antibody Response to Hepatitis B Immunization in Children With Intestinal Failure: Before and After Small Bowel Transplantation (With and Without Liver Graft).
    Craggs HM; Jackson P; Gupte G; Hartley J; Abdel-Hady M; Morton R; Beath S; Hogg L
    JPEN J Parenter Enteral Nutr; 2017 Aug; 41(6):1030-1036. PubMed ID: 26962060
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation.
    Rosenau J; Hooman N; Hadem J; Rifai K; Bahr MJ; Philipp G; Tillmann HL; Klempnauer J; Strassburg CP; Manns MP
    Liver Transpl; 2007 Mar; 13(3):367-73. PubMed ID: 17318859
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low-dose anti-hepatitis B immunoglobulin regimen as prophylaxis for hepatitis B recurrence after liver transplantation.
    Lee WC; Chou HS; Wu TH; Cheng CH; Lee CF; Wang YC; Wu TJ; Chan KM
    Transpl Infect Dis; 2019 Dec; 21(6):e13190. PubMed ID: 31587427
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Utilization of hepatitis B core antibody positive grafts in living donor liver transplantation.
    Udayakumar VP; Surendran S; Padma UD
    Indian J Gastroenterol; 2018 Jan; 37(1):39-43. PubMed ID: 29450703
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis.
    Joya-Vazquez PP; Dodson FS; Dvorchik I; Gray E; Chesky A; Demetris AJ; Shakil O; Fung JJ; Vargas HE
    Transplantation; 2002 May; 73(10):1598-602. PubMed ID: 12042646
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High prevalence of hepatitis B-antibody loss and a case report of
    Sintusek P; Posuwan N; Wanawongsawad P; Jitraruch S; Poovorawan Y; Chongsrisawat V
    World J Gastroenterol; 2018 Feb; 24(6):752-762. PubMed ID: 29456414
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effectiveness of hepatitis B vaccination in chronic HCV patients after successful generic direct acting antiviral therapy: significance of isolated hepatitis B core antibodies.
    Abd El-Wahab EW; Metwally M; Lotfy N
    Trop Med Int Health; 2021 Aug; 26(8):882-894. PubMed ID: 33860608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.